- Home
- EVOK vs INBS Comparison
EVOK vs INBS Comparison
Compare EVOK & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- INBS
- Stock Information
- Founded
- EVOK 2007
- INBS 2016
- Country
- EVOK United States
- INBS United States
- Employees
- EVOK N/A
- INBS N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- EVOK Health Care
- INBS Health Care
- Exchange
- EVOK Nasdaq
- INBS Nasdaq
- Market Cap
- EVOK 6.5M
- INBS 6.4M
- IPO Year
- EVOK 2013
- INBS N/A
- Fundamental
- Price
- EVOK $4.47
- INBS $1.40
- Analyst Decision
- EVOK
- INBS
- Analyst Count
- EVOK 0
- INBS 0
- Target Price
- EVOK N/A
- INBS N/A
- AVG Volume (30 Days)
- EVOK 29.5K
- INBS 71.7K
- Earning Date
- EVOK 03-13-2025
- INBS 02-07-2025
- Dividend Yield
- EVOK N/A
- INBS N/A
- EPS Growth
- EVOK N/A
- INBS N/A
- EPS
- EVOK N/A
- INBS N/A
- Revenue
- EVOK $8,617,036.00
- INBS $3,187,974.00
- Revenue This Year
- EVOK $97.35
- INBS $280.88
- Revenue Next Year
- EVOK $99.52
- INBS $126.26
- P/E Ratio
- EVOK N/A
- INBS N/A
- Revenue Growth
- EVOK 100.35
- INBS 55.29
- 52 Week Low
- EVOK $3.54
- INBS $1.00
- 52 Week High
- EVOK $12.32
- INBS $11.70
- Technical
- Relative Strength Index (RSI)
- EVOK 47.52
- INBS 48.80
- Support Level
- EVOK $4.30
- INBS $1.36
- Resistance Level
- EVOK $4.58
- INBS $1.47
- Average True Range (ATR)
- EVOK 0.26
- INBS 0.08
- MACD
- EVOK -0.00
- INBS 0.01
- Stochastic Oscillator
- EVOK 48.22
- INBS 48.15
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).